Walden, United Kingdom

Lucille Le Bozec

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: C4x Discovery Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucille Le Bozec. Retrieved from https://idiyas.com/inventor/lucille-le-bozec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucille Le Bozec: Innovator in Therapeutic Compounds

Introduction

Lucille Le Bozec is a prominent inventor based in Walden, GB. She has made significant contributions to the field of therapeutic compounds, particularly those that activate the Nrf2 pathway. Her innovative work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Lucille holds a patent for therapeutic compounds that are Nrf2 activators. The present invention relates to compounds with a specific structural formula, which are designed to enhance Nrf2 activation. This patent also encompasses processes for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating diseases associated with Nrf2 activation. She has 1 patent to her name.

Career Highlights

Lucille is currently associated with C4X Discovery Limited, where she continues to advance her research and development efforts. Her work at this company reflects her commitment to innovation in the pharmaceutical industry.

Collaborations

Lucille collaborates with notable colleagues, including Emma Louise Blaney and Duncan J Crick. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Lucille Le Bozec is a trailblazer in the field of therapeutic compounds, with a focus on Nrf2 activation. Her contributions are paving the way for new treatments and advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…